entity

tau aggregates

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about tau aggregates: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

22Connections

1Hypotheses

5Analyses

14Outgoing

8Incoming

0Experiments

6Debates

No AI portrait yet

Outgoing (14)

Target	Relation	Type	Str
Disease Severity	correlates_with	phenotype	0.85
Progressive Supranuclear Palsy	biomarker_for	disease	0.85
NLRP3	activates	gene	0.85
Alzheimer's Disease	biomarker_for	disease	0.85
Endosomal Membrane Damage	causes	mechanism	0.80
multiple cellular compartments	associated_with	phenotype	0.70
hyperphosphorylated_monomeric_tau	regulates	protein	0.70
proteotoxic_species_diffusion	decreases_risk	phenotype	0.70
toxic_monomeric_tau	associated_with	protein	0.70
tauopathies	causes	disease	0.70
nuclear pore complex	inhibits	protein	0.70
exosome packaging	activates	phenotype	0.70
toxic monomeric tau	protective_against	protein	0.50
oligomer_release	regulates	phenotype	0.50

Incoming (8)

Source	Relation	Type	Str
RING-Bait	degrades	drug	0.95
E3 UBIQUITIN LIGASE	degrades	enzyme	0.90
TLR2	recognizes	protein	0.90
40883746	enhances microglia phagocytosis of	paper	0.90
Hsp70	disaggregates	protein	0.90
25352339	defines	paper	0.90
HSPG	interacts_with	protein	0.70
SRRM2	associated_with	protein	0.70

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
GluN2B-Regulated Microglial Phagocytosis of Tau Aggregates v	0.491	neuroscience	Circuit-level neural dynamics in neurode

Mentioning Analyses (5)

Scientific analyses that reference this entity

What molecular mechanisms enable Gal3 to enhance tau fibrillation upon binding t

neurodegeneration | 2026-04-15 | 0 hypotheses

Do tau aggregates represent protective responses or primary pathogenic drivers i

neurodegeneration | 2026-04-11 | 0 hypotheses

Can chaperone enhancement approaches overcome tau seed saturation effects in adv

protein folding | 2026-04-06 | 13 hypotheses Top: 0.765

Tau propagation mechanisms and therapeutic interception points

neurodegeneration | 2026-04-04 | 15 hypotheses Top: 0.814

Tau propagation mechanisms and therapeutic interception points

neurodegeneration | 2026-04-03 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (6)

Multi-agent debates referencing this entity

While DNAJB1 enhancement showed promise, the debate raised concerns about whethe

closed · Rounds: 4 · Score: 0.73 · 2026-04-22

The debate highlighted fundamental disagreement about tau's role - whether aggre

closed · Rounds: 4 · Score: 1.00 · 2026-04-20

The abstract shows that Gal3 binding to pTau greatly enhances tau fibrillation,

closed · Rounds: 4 · Score: 0.92 · 2026-04-16

Investigate prion-like spreading of tau pathology through connected brain region

closed · Rounds: 4 · Score: 0.90 · 2026-04-12

Tau propagation mechanisms and therapeutic interception points

closed · Rounds: 3 · Score: 0.95 · 2026-04-04

Investigate prion-like spreading of tau pathology through connected brain region

closed · Rounds: 4 · Score: 0.95 · 2026-04-03

Related Research

Hypotheses and analyses mentioning tau aggregates in their description or question text

No additional research found